
45.96 Delayed Data As of Sep 29 | ![]() Today’s Change | 26.76 Today|||52-Week Range 67.66 | +64.03% Year-to-Date |
The 3 analysts offering 12-month price forecasts for Amphastar Pharmaceuticals Inc have a median target of 70.00, with a high estimate of 71.00 and a low estimate of 66.00. The median estimate represents a +52.31% increase from the last price of 45.96.
The current consensus among 4 polled investment analysts is to Buy stock in Amphastar Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.